Vortioxetine

CHEMBL2104993 Phase 4 معتمد Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
298.4 g/mol
LogP
4.2
Phase
4

This multimodal antidepressant is used to treat major depressive disorder and works by both blocking serotonin reuptake and modulating multiple serotonin receptor subtypes, which may offer benefits for mood and cognitive function. Unlike some antidepressants, it may improve concentration and memory alongside mood. Sexual side effects are generally less common than with typical SSRIs.

الوزن الجزيئي

298,4000 g/mol

LogP

4,20

TPSA

40,60 Ų

قاعدة ليبينسكي للخمسة

ناجح

المجالات العلاجية

Pharmacokinetics (PK)

Pharmacodynamics (PD)

البنية ثنائية الأبعاد

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

Cc1ccc(Sc2ccccc2N2CCNCC2)c(C)c1

InChI

InChI=1S/C18H22N2S/c1-14-7-8-17(15(2)13-14)21-18-6-4-3-5-16(18)20-11-9-19-10-12-20/h3-8,13,19H,9-12H2,1-2H3

Molecular Formula

C18H22N2S

HBD / HBA

1 / 3

الروابط القابلة للدوران

3

الذرات الثقيلة

21

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

الأسئلة الشائعة

This multimodal antidepressant is used to treat major depressive disorder and works by both blocking serotonin reuptake and modulating multiple serotonin receptor subtypes, which may offer benefits for mood and cognitive function. Unlike some antidepressants, it may improve concentration and memory alongside mood. Sexual side effects are generally less common than with typical SSRIs.

Yes, Vortioxetine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2104993. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 9966051. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

إخلاء المسؤولية الطبية

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.